Crohn's Disease

SEP 4, 2026 · PHASE 3 TRIAL

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

ClinicalTrials.gov

This is a Phase 3 registry record with no reported results; the study is actively recruiting and designed to test a combination approach in a dual-disease population, but outcomes remain unreported.

AUG 27, 2026 · JOURNAL ARTICLE

Polyglycolic Acid Shield Prevents Repeated Delayed Bleeding After Endoscopic Stricturotomy for Anastomotic Stricture in Crohn's Disease: A Case Report.

Den Open

A single case report describing a novel application of polyglycolic acid sheeting for a complication of endoscopic stricturotomy; no control group, no comparative data, and no quantitative evidence of efficacy beyond one patient's outcome.